Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Photo of Dr Anna Kaufmann and Dr Achim Sauer

Careers: Winning with people

Empowering our employees

Read more
Financial Highlights
About us

Financial Highlights 2021

Net sales, Research and Development expenditures, Operating Income and Personnel Capacity: Boehringer Ingelheim grows
Read more
Annual Report 2021

Annual Report 2021: Tomorrow

Tomorrow holds great opportunities for more progress, more sustainability, and better health. Read inspiring stories on our understanding of a healthier future in our annual report.

Related Press Releases